Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Clin Pharmacokinet. 2018 Feb;57(2):209–219. doi: 10.1007/s40262-017-0553-1

Table 3.

Weight, absolute dosage, and exposure parameters of dosing cohorts

Dose (mg/kg) Weight (kg) Dose (mg) Cmax (mg/L) C24 (mg/L) Half-life (h) AUC24 (h•mg/L) AUCinf (h•mg/L)
15 78.8 (14.3) 1182 (214) 112 (11.8) 22.6 (5.64) 12.1 (1.8) 1184 (152) 1714 (340)
30 71.7 (9.6) 2151 (288) 235 (21.1) 39.5 (11.8) 12.1 (3.4) 2205 (311) 3386 (1033)
60 66.8 (6.9) 4009 (412) 248 (25.4) 39.8 (2.83) 11.3 (2.1) 2241 (174) 3043 (377)
90 77.4 (14.7) 6966 (1322) 541 (62.3) 56.9 (25.4) 8.9 (1.5) 4626 (1044) 5812 (1424)
120 74.9 (12.2) 8990 (1467) 537 (70.7) 49.7 (19.7) 9.0 (2.1) 3843 (723) 4983 (1332)
130 82.1 (9.5) 10667 (1231) 855 (90.1) 97.2 (11.9) 8.8 (2.3) 7745 (1404) 11273 (1658)
140 77.9 (6.8) 10899 (955) 1271 (178) 140 (19.3) 9.7 (1.0) 9870 (898) 13520 (1621)
150 64.2 (4.4) 9630 (658) 694 (62.9) 81.4 (34.7) 7.9 (3.7) 6911 (571) 8521 (226)

Values reported as mean (standard deviation).